Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 39 of 115 for:    "Viral Infectious Disease" | "Ledipasvir"

Efficacy of All-Oral Anti-Viral Therapy for Symptomatic Hepatitis C Virus Infection-Related Cryoglobulinemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02825212
Recruitment Status : Completed
First Posted : July 7, 2016
Last Update Posted : August 6, 2019
Sponsor:
Collaborator:
Gilead Sciences
Information provided by (Responsible Party):
Peter Gorevic, Icahn School of Medicine at Mount Sinai

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 19, 2019
Actual Study Completion Date : July 19, 2019
Publications:
Diagnosis and treatment of HCV-related mixed cryoglobulinemia over the last decade at a Liver Referral Center Ando, Y, Gorevic, PD, Schiano TD. Hepatology 58 2013 : 1443 abstract
Gorevic, PD; "Mixed Cryoglobulinemia Cross-reactive Idiotypes: Structural and Clinical Significance" Cryoglobulinemia & Hepatitis C Infection, Dammacco, F (Editor); Springer Verlag, 2012, p. 99-107.
Gorevic PD and Galanakis DK;